MUSE™ SYSTEM - GERD Relief in Sight

GERD is caused by abnormal regurgitation of fluids from the stomach into the esophagus.
  • srs-home-6
  • srs-home-5
  • srs-home-4
  • srs-home-2
  • srs-home-3
  • srs-home-7
  • srs-home-1

The MUSE™ innovative system offers incisionless treatment of Gastroesophageal Reflux Disease (GERD) by performing an anterior fundoplication in lieu of current surgical procedures, without opening the abdominal cavity.

The MUSE™ System is FDA cleared, CE marked and manufactured under ISO13485:2003.


SRS SYSTEM - Leading the gerd revolution

Medigus is leading the transition from invasive gastric surgery procedures to less invasive, patient-friendly techniques through the development of minimally invasive endoscopic devices and procedures. The company's revolutionary MUSE™ System enables endoscopists to treat gastroesophageal reflux disease (GERD), a chronic disease with increasing global prevalence, by performing a fundoplication procedure through the mouth.  Unlike current fundoplication procedures, the MUSE™ System does not require abdominal incisions, which may result in shorter post-procedure recovery.  The MUSE™ System (previously known as SRS™ System for transoral fundoplication) has received FDA clearance and CE mark. Medigus is traded on the Nasdaq Capital Market and the TASE (Tel-Aviv Stock Exchange).

News & Events